COGNICURRENT

The FDA has begun reevaluating the safety of the food additive BHA, which is commonly used in many processed foods and is expected to be legally removed from American menus due to safety concerns.

A new ADHD drug called centanafadine is awaiting FDA approval and presents potential changes in treatment options.

The FDA chief, Marty Makary, expresses support for mRNA vaccines while stating that American taxpayers shouldn't bear the costs of new research.

Experts warn that certain dietary supplements could pose health risks for individuals with diabetes due to their potential impact on blood glucose levels and interactions with medications.

The Trump-era FDA has relaxed rules on food labeling concerning artificial colors, allowing misleading claims that could pose health risks to consumers.

Moderna has announced that the FDA has reversed its decision and will analyze its new flu vaccine, which uses mRNA technology.

The FDA has decided to review Moderna's application for its mRNA-based flu vaccine after initially declining it, responding to criticism regarding its decision-making processes.

The FDA initially rejected Moderna's application for a new flu vaccine but has since agreed to review it based on new regulatory pathways for older adults following a constructive meeting.

The article discusses how Donald Trump's political actions in the U.S. may impede the development of a promising cancer vaccine based on mRNA technology.

Sen. Tom Cotton is urging the FDA to investigate the infiltration of illegal Chinese ingredients into weight loss drugs sold in the United States, citing national and health security concerns.

The FDA declined to review Moderna's mRNA flu vaccine application, prompting concerns that the decision may be influenced by anti-vaccine sentiment rather than scientific rigor.

Senator Josh Hawley is urging Congress to increase oversight of the abortion pill Mifepristone, citing a failure by the FDA to complete promised safety studies and a rising number of abortions in the U.S.

Moderna asserts that the US FDA has declined to review its mRNA-based flu vaccine due to concerns over inadequate clinical trials and lack of proper comparison with existing products.

The FDA has declined to review Moderna's mRNA flu vaccine application, potentially delaying its introduction for older adults.

US regulators have refused to review Moderna's request for a new flu vaccine, raising concerns about the future of flu vaccination efforts in the country.

Novo Nordisk is preparing a response to the FDA over concerns regarding a misleading TV advertisement for its Wegovy weight-loss pill.

Novo Nordisk is preparing a response to the FDA regarding a letter that stated an advertisement for its Wegovy pill was misleading or false.

Novo Nordisk's stock surged approximately 8% following Hims & Hers's decision to withdraw a low-cost weight loss pill similar to Wegovy amid legal threats from both Novo Nordisk and the FDA.

The American telehealth company Hims and Hers has decided to cease the sale of a copy of Novo's weight loss medication Wegovy after discussions with industry stakeholders.

The FDA has approved a dual-action eye drop designed to restore near vision for individuals suffering from presbyopia, a condition common in aging populations.

The FDA has announced a relaxation of rules, allowing companies to label products as 'no artificial colors' if the coloring is natural or plant-based, enabling greater flexibility for manufacturers.

A pro-life group claims that a Biden-era FDA policy facilitating mail-order abortion pills is responsible for a rise in abortions, which could be reversed by the Trump administration.

New research highlights that low daily doses of aspirin may reduce the risk of cardiovascular diseases for some individuals, but the FDA recommends such use only under medical supervision, especially for those over 60.

The FDA has requested pharmaceutical companies to remove warnings about potential suicidal thoughts from labels of common weight-loss medications, including Novo Nordisk's 'Wegovy' and Eli Lilly's 'Zyban', following a comprehensive review that found no link to such thoughts.

Former FDA employees caution that budget cuts and politicization under Trump threaten food safety, highlighted by a recent listeria outbreak linked to contaminated pasta.

A new analysis reveals that the FDA's decisions regarding the abortion pill were grounded in scientific evidence.

The program highlights groundbreaking medical advancements in treating chronic and rare diseases, including FDA approval of a new daily oral medication for weight loss and a gene therapy for spinal muscular atrophy.

Doctors warn that many dietary supplements are neither safe nor effective, urging people to stop using four specific products that lack approval from the FDA and strong clinical evidence supporting their claims.

The U.S. FDA's decision to remove the 'Black Box' warning from hormone treatments for menopausal women may have wider implications beyond the country's borders.

A stronger weight loss drug, retatrutide, not yet approved by the FDA, is emerging on the black market, promising significant weight loss but posing serious risks.